Ultrasensitive MRD Assays for Rapid Turnaround Times
Jeremiah McDole, PhD
Liquid biopsies require a modern quantification approach to maximize sensitivity
liquid biopsy
Are Risk-Based MCED Tests the Future of Cancer Screening?
Swathi Kodaikal, MSc
Done early enough, personalized, patient data-driven multi-cancer screening will save lives. But are we there yet?
New Prediction Model Aids in Early Detection of Preeclampsia
Swathi Kodaikal, MSc
The model analyzes methylation changes in the cell-free DNA of pregnant women at risk of preeclampsia
Testing for Noncoding RNA Improves Cancer Detection
University of California - Santa Cruz
A novel liquid biopsy technology leverages cell-free RNA “dark matter” to enhance cancer diagnosis
Next-Generation Liquid Biopsy Detects Nano-Sized Signs of Breast Cancer
University of Southern California
Researchers find remarkable results with the blood test in a small group of breast cancer patients
Monitoring How Tumors Respond to Treatment with ctDNA
Erica Tennenhouse, PhD
ctDNA assays can facilitate tracking of a tumor's response to treatment over time
New Liquid Biopsy IDs Lymph Node Metastasis in Early-Stage T1 Colorectal Cancer
City of Hope
The new, blood-based test could help people with non-high-risk early-stage colorectal cancer avoid unnecessary surgery
Liquid Biopsies Offer Quicker, Easier Lung Cancer Testing
Pat Carragher, Endeavor, Moffitt Cancer Center
A new liquid biopsy test uses next-generation sequencing to identify specific mutations in NSCLC
The Key to Increased Sensitivity in Liquid Biopsy
Erica Tennenhouse, PhD
Higher conversion increases data quality and accuracy of results
The Power of Predictive Biomarkers
George Karlin-Neumann, PhD
ddPCR-based liquid biopsies can provide reliable and timely biomarker information to help guide treatment decisions